[{"address1": "333 Las Olas Way", "address2": "CU4 Suite 433", "city": "Fort Lauderdale", "state": "FL", "zip": "33301", "country": "United States", "phone": "(954) 330-0684", "website": "https://sunshinebiopharma.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Sunshine Biopharma, Inc. operates as a pharmaceutical company that focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates through Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products segments. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; Adva-27a, a small chemotherapy molecule to treat pancreatic cancer; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, and anticonvulsant indications. Sunshine The company is based in Fort Lauderdale, Florida.", "fullTimeEmployees": 52, "companyOfficers": [{"maxAge": 1, "name": "Dr. Steve N. Slilaty Ph.D.", "age": 72, "title": "Chairman, President & CEO", "yearBorn": 1952, "fiscalYear": 2024, "totalPay": 1291587, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Camille  Sebaaly", "age": 65, "title": "CFO & Secretary", "yearBorn": 1959, "fiscalYear": 2024, "totalPay": 352031, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Abderrazzak  Merzouki", "age": 60, "title": "COO & Director", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 366625, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Malek  Chamoun", "age": 39, "title": "Chief Development Officer", "yearBorn": 1985, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michel  Roy", "age": 56, "title": "Chief Commercial Officer", "yearBorn": 1968, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert G. Ferreira", "age": 62, "title": "President of Sunshine Bio Investments Inc", "yearBorn": 1962, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.44, "open": 1.42, "dayLow": 1.3737, "dayHigh": 1.44, "regularMarketPreviousClose": 1.44, "regularMarketOpen": 1.42, "regularMarketDayLow": 1.3737, "regularMarketDayHigh": 1.44, "payoutRatio": 0.0, "forwardPE": 0.0071571567, "volume": 43691, "regularMarketVolume": 43691, "averageVolume": 1434057, "averageVolume10days": 99840, "averageDailyVolume10Day": 99840, "bid": 1.4, "ask": 1.45, "bidSize": 1, "askSize": 1, "marketCap": 6514994, "fiftyTwoWeekLow": 1.169, "fiftyTwoWeekHigh": 12.8, "priceToSalesTrailing12Months": 0.17980048, "fiftyDayAverage": 1.5441, "twoHundredDayAverage": 2.471335, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -730883, "profitMargins": -0.13881999, "floatShares": 4181127, "sharesOutstanding": 4555940, "sharesShort": 258996, "sharesShortPriorMonth": 121975, "sharesShortPreviousMonthDate": 1744675200, "dateShortInterest": 1747267200, "sharesPercentSharesOut": 0.056799997, "heldPercentInsiders": 0.03167, "heldPercentInstitutions": 0.082650006, "shortRatio": 0.36, "shortPercentOfFloat": 0.056900002, "impliedSharesOutstanding": 4555940, "bookValue": 8.38, "priceToBook": 0.17064439, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -5030086, "trailingEps": -5.76, "forwardEps": 199.8, "lastSplitFactor": "1:20", "lastSplitDate": 1723075200, "enterpriseToRevenue": -0.02, "enterpriseToEbitda": 0.133, "52WeekChange": -0.8786078, "SandP52WeekChange": 0.1189177, "quoteType": "EQUITY", "currentPrice": 1.43, "targetHighPrice": 140.0, "targetLowPrice": 140.0, "targetMeanPrice": 140.0, "targetMedianPrice": 140.0, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 1, "totalCash": 8195067, "totalCashPerShare": 1.799, "ebitda": -5511580, "totalDebt": 936182, "quickRatio": 2.02, "currentRatio": 4.248, "totalRevenue": 36234576, "debtToEquity": 4.124, "revenuePerShare": 29.768, "returnOnAssets": -0.11781, "returnOnEquity": -0.21169001, "grossProfits": 11045883, "freeCashflow": -10590578, "operatingCashflow": -11059857, "revenueGrowth": 0.18, "grossMargins": 0.30484, "ebitdaMargins": -0.15211001, "operatingMargins": -0.14557, "financialCurrency": "USD", "symbol": "SBFM", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "postMarketChangePercent": -2.0979, "postMarketPrice": 1.4, "postMarketChange": -0.03, "regularMarketChange": -0.01000011, "regularMarketDayRange": "1.3737 - 1.44", "shortName": "Sunshine Biopharma Inc.", "longName": "Sunshine Biopharma, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1644935400000, "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1434057, "fiftyTwoWeekLowChange": 0.26099992, "fiftyTwoWeekLowChangePercent": 0.22326767, "fiftyTwoWeekRange": "1.169 - 12.8", "fiftyTwoWeekHighChange": -11.37, "fiftyTwoWeekHighChangePercent": -0.8882812, "fiftyTwoWeekChangePercent": -87.86078, "dividendDate": 1586131200, "earningsTimestamp": 1747339200, "earningsTimestampStart": 1755201600, "earningsTimestampEnd": 1755547200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -5.76, "epsForward": 199.8, "corporateActions": [], "postMarketTime": 1748648366, "regularMarketTime": 1748635200, "exchange": "NCM", "messageBoardId": "finmb_78729055", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -0.69445205, "regularMarketPrice": 1.43, "marketState": "CLOSED", "fiftyDayAverageChange": -0.1141001, "fiftyDayAverageChangePercent": -0.07389424, "twoHundredDayAverageChange": -1.041335, "twoHundredDayAverageChangePercent": -0.42136538, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2022-02-15", "averageAnalystRating": "1.0 - Strong Buy", "cryptoTradeable": false, "displayName": "Sunshine Biopharma", "trailingPegRatio": null, "__fetch_time": "2025-05-31"}]